Seminars in Oncology
Volume 35, Issue 2 , Pages 129-133 , April 2008

The Role of Thoracoscopy in the Management of Cancer Patients

  • Mark J. Krasna

      Affiliations

    • Corresponding Author InformationAddress correspondence to Mark J. Krasna, MD, Medical Director, St. Joseph Cancer Institute, 7501 Osler Dr, Suite 104, Towson, MD 21204.

References 

  1. Krasna MJ. Atlas of thoracoscopic surgery. St Louis: Quality Medical Publishing; 1993;
  2. Viallat JR, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. Chest. 1996;110:1387–1393
  3. Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997;349:251–252
  4. Cardillo G, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothoracic Surg. 2002;21:302–305
  5. De Campos JR, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119:801–806
  6. Antunes G, Neville E, Duffy J, Ali N, et al. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58(Suppl 2):ii29–ii38
  7. Reich H, Beattie EJ, Harvey JC. Pleuroperitoneal shunt for malignant pleural effusions: a one-year experience. Semin Surg Oncol. 1993;9:160–162
  8. Putnam JB, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86:1992–1999
  9. Dresler CM, Olak J, Herndon JE, Richards WG, Scalzetti E, Fleishman SB, et al. Phase III intergroup study of talc poudrage versus talc slurry sclerosis for malignant pleural effusions. Chest. 2005;127:909–915
  10. Zimmer PV, Hill M, Casey K, Harvey E, Low DE. Prospective randomized trial of talc slurry versus bleomycin in the management of malignant pleural effusions. Chest. 1997;112:430
  11. Templeton P, Krasna MJ. Needle/wire lung nodule localization for thoracoscopic resection. Chest. 1993;104:953–954
  12. Demmy TL, Krasna MJ, Detterbeck FC, Kline GG, Kohman LJ, DeCamp MM, et al. Multicenter VATS experience with mediastinal tumors. Ann Thorac Surg. 1998;66:187–192
  13. Fiocco M, Krasna MJ. Thoracoscopic lymph node dissection in the staging of esophageal cancer. J Laparoendosc Surg. 1992;2:111–115
  14. Fiocco M, Krasna MJ. The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am. 1997;11:253–265
  15. Mack MJ, Landreneau RJ, Hazelrigg SR, Acuff TE. Video thoracoscopic management of benign and malignant pericardial effusions. Chest. 1993;103:390S–393S
  16. Murray GF, Wilcox BR, Starek PJ. The assessment of operability of esophageal carcinoma. Ann Thorac Surg. 1977;23:393–399
  17. Dagnini G, Caldironi MW, Marin G, et al. Laparoscopy in abdominal staging of esophageal carcinoma (Report of 369 cases). Gastrointest Endosc. 1986;32:400–402
  18. Stein HJ, Kraemer SJ, Feussner H. Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia. J Gastrointest Surg. 1997;1:167–172
  19. Krasna MJ, Flowers JL, Attar S, et al. Combined thoracoscopic/laparoscopic staging of esophageal cancer. J Thorac Cardiovasc Surg. 1996;111:800–806
  20. Krasna MJ, Reed CE, Nedzwiecki W, et al. CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer. Ann Thorac Surg. 2001;71:1073–1079
  21. Kassis ES, Nguyen N, Shriver SP, et al. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques. J Soc Laparoendosc Surg. 1998;2:331–336
  22. Godfrey TE, Raja S, Finkelstein SD, et al. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res. 2001;7:4041–4048
  23. Krasna MJ, Mao YS, Sonnett JR, et al. P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg. 1999;68:2021–2024

PII: S0093-7754(07)00278-3

doi: 10.1053/j.seminoncol.2007.12.009

Seminars in Oncology
Volume 35, Issue 2 , Pages 129-133 , April 2008